BAST BIOTECHNOLOGY
Bast Biotechnology has developed innovative technology to fight fibrotic disease. The intial indication will target non-alcolic fibrotic liver disease (NAFLD) and non-alcoholic steatosis hepatitis (NASH).
BAST BIOTECHNOLOGY
Industry:
Biotechnology Therapeutics
Address:
Chicago, Illinois, United States
Country:
United States
Website Url:
http://www.bastbiotech.com
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Content Delivery Network Apache Microsoft Exchange Online Organization Schema Office 365 Mail IPv6
